LITTLE FALLS, N.J., Oct. 3, 2011 /PRNewswire/ -- CANTEL MEDICAL CORP.'s (NYSE: CMN) Minneapolis, MN based subsidiary, Minntech Corporation, has been named by the Minnesota High Tech Association (MHTA), as one of three finalists in the Life Sciences Award - Established Companies Category for the 2011 Tekne Awards. The Tekne Awards recognize Minnesota companies and individuals who have shown superior technology innovation and leadership. The awards ceremony will be held at the Minneapolis Convention Center on Thursday, November 3, 2011.
Minntech was honored as a finalist from among the top tech-based companies in Minnesota for its latest advancement in innovation and product sterilization technology: REVOX(SM) Contract Sterilization Services. Developed by Cantel Infection Prevention and Control Chemistries (IPCC), a new business unit formed at Minntech in 2010, the REVOX service is the only rapid turnaround, true room-temperature vapor sterilization (18 – 30 degrees C) offering for the medical, pharmaceutical and consumer products industries. The technology allows heat-sensitive devices to be sterilized without compromising materials compatibility, product quality or integrity, and also significantly reduces the preparation time of the sterilization process that is associated with other methods.
"We are excited to be named as a finalist for the Tekne Award and be recognized for our innovation," said Andrew Krakauer, President and CEO, Cantel Medical Corp. "Minntech's recent technological advancements in the sterilization arena, combined with outstanding customer support, have provided significant value to our customers. We will continue to provide new and innovative products and services to infection prevention and control markets."
Presented by the MHTA, the Tekne Awards annually recognize Minnesota's best and brightest technology users and developers in innovation, development, education, commercialization and management. A full list of finalists is available online at http://www.tekneawards.org.
About Cantel Infection Prevention & Control Chemistries (IPCC)
Cantel IPCC is a Business Group of Minntech Corporation, a subsidiary of Cantel Medical Corp. IPCC delivers infection prevention solutions for healthcare, consumer, pharmaceutical and industry customers through proprietary chemistries and innovative equipment and services. For more information, visit www.minntech.com
About Cantel Medical Corp.
Cantel Medical Corp. (NYSE: CMN) is a leading provider of infection prevention and control products in the healthcare market. Our products include water purification equipment, sterilants, disinfectants and cleaners, specialized medical device reprocessing systems for endoscopy and renal dialysis, disposable infection control products primarily for the dental industry, dialysate concentrates and other dialysis supplies, hollow fiber membrane filtration and separation products for medical and non-medical applications, and specialty packaging for infectious and biological specimens. We also provide technical maintenance for our products and offer compliance training services for the transport of infectious and biological specimens. For further information, visit the Cantel website at www.cantelmedical.com
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve a number of risks and uncertainties, including, without limitation, the risks detailed in Cantel's filings and reports with the Securities and Exchange Commission. Such forward-looking statements are only predictions, and actual events or results may differ materially from those projected or anticipated.
SOURCE Cantel Medical Corp.